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The burgeoning epidemic of diabetes mellitus (DM) is one of the major global health chal-
lenges. We systematically reviewed the published literature to provide a summary estimate
of the association between DM and active tuberculosis (TB). We searched Medline and
EMBASE databases for studies reporting adjusted estimates on the TB–DM association
published before December 22, 2015, with no restrictions on region and language. In the
meta-analysis, adjusted estimates were pooled using a DerSimonian-Laird random-effects
model, according to study design. Risk of bias assessment and sensitivity analyses were
conducted. 44 eligible studies were included, which consisted of 58,468,404 subjects from
16 countries. Compared with non-DM patients, DM patients had 3.59–fold (95% confidence
interval (CI) 2.25–5.73), 1.55–fold (95% CI 1.39–1.72), and 2.09–fold (95% CI 1.71–2.55)
increased risk of active TB in four prospective, 16 retrospective, and 17 case-control stud-
ies, respectively. Country income level (3.16–fold in low/middle–vs. 1.73–fold in high–
income countries), background TB incidence (2.05–fold in countries with >50 vs. 1.89–fold
in countries with50 TB cases per 100,000 person-year), and geographical region (2.44–
fold in Asia vs. 1.71–fold in Europe and 1.73–fold in USA/Canada) affected appreciably the
estimated association, but potential risk of bias, type of population (general versus clinical),
and potential for duplicate data, did not. Microbiological ascertainment for TB (3.03–fold)
and/or blood testing for DM (3.10–fold), as well as uncontrolled DM (3.30–fold), resulted in
stronger estimated association. DM is associated with a two- to four-fold increased risk of
active TB. The association was stronger when ascertainment was based on biological test-
ing rather than medical records or self-report. The burgeoning DM epidemic could impact
upon the achievements of the WHO “End TB Strategy” for reducing TB incidence.
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Introduction
Despite the decline in the mortality rate of active tuberculosis (TB) since 1990, TB is ranked as
one of the leading causes of death [1]. In 2015, there were an estimated 10.4 million incident
TB cases worldwide [1]. The “End TB Strategy” launched by the World Health Organization
(WHO) in 2016, aims to end the global TB epidemic by 2035 [1]. Targets set in this strategy
include 90% reduction in TB deaths and an 80% reduction in TB incidence by 2030, compared
with 2015 [1].
The growing epidemic of diabetes mellitus (DM) is set to become one of the major global
health challenges [2]. The number of individuals with DM is projected to rise from 415 million
in 2015 to 642 million by 2040 [3]. It is estimated that over a million TB cases among adults
were affected by DM in 2012 [4]. The rising DM epidemic could contribute to an increase in
TB burden. Although a few studies have failed to confirm a positive association between TB
and DM [5–7], other studies reported a strong association between DM and active TB [8–12].
Based on earlier published summary effect estimates, DM increases the risk of active TB by
3.11–fold [13] and latent TB by 1.18–fold [14]. DM also has a major effect on TB treatment
outcomes [15, 16]; in particular, it is associated with delayed sputum culture conversion,
increased risk of treatment failure, and increased risk of TB relapse and mortality [17]. With
the accumulation of recent evidence supporting the TB–DM association, there is a need for an
updated understanding of the magnitude of the TB–DM association. This understanding is
critical for implementation of comprehensive TB and DM control programs.
In this study, we aimed to systematically review the published literature on the association
between active TB and DM, and to statistically summarize the evidence on the strength of the
association.
Materials and methods
Search strategy and selection criteria
This review follows Cochrane Collaboration guidelines [18] and reports findings using the
Preferred Reporting Items for Systematic reviews and Meta-analyses (PRISMA) guidelines
[19].
We searched Medline (from 1945 to December 22, 2015) and EMBASE (from 1980 to
December 22, 2015) databases, for studies on the TB–DM association. For inclusiveness, our
search strategy covered studies that examined any risk factor for TB. The literature search pro-
tocol is summarized in the S1 Box.
Inclusion of studies was restricted to human studies that provided an estimate or allowed us
to compute an estimate of the association, adjusted at least for one variable. No restrictions
were made on study language, population, publication year, or region.
We excluded studies: amongst animals or children, if qualitative in design, case reports,
case series, reviews, anonymous reports, editorials or author commentaries, with no appropri-
ate control arm or comparator group, where TB patients with DM were not separated from
those with other co-morbidities, of TB outcomes rather than the association, that did not
report adjusted estimates of the TB–DM association, and duplicate reports.
We contacted authors of potentially eligible studies to provide the adjusted estimate for the
association, if the adjusted estimate was not included in the publication. Studies whose authors
did not respond were excluded. The flow diagram of study selection is shown in Fig 1. First
author (RHA) screened all titles and abstracts, reviewed full-text articles, and assessed their eli-
gibility for inclusion.
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Data extraction and quality assessment
Three authors (RHA, JAC, and LJA) designed the literature search terms and strategy. All
potentially relevant full-text articles retrieved and reviewed to confirm eligibility. If eligible,
data were extracted. All authors (RHA, FP, JAC, and LJA) contributed in assessing the eligibil-
ity of the included studies. The first author (RHA) extracted the data, which were re-extracted
independently by at least one co-author (FP, JAC, or LJA). Discrepancies in data extraction
were resolved by consensus or consultation with a third co-author. In addition to extracting
baseline characteristics of included studies, we assessed methodological aspects, such as sam-
pling strategy, characteristics of the study population, and TB and DM ascertainment. If a
study reported more than one adjusted estimate or stratified adjusted estimates, we chose the
most representative and relevant estimate with the most confirmatory DM (i.e. prioritizing
HbA1c over fasting blood glucose (FBG)) and/or TB (i.e. prioritizing bacterial culture over X-
ray) ascertainment strategy, or the estimate adjusted for the largest number of appropriate var-
iables when the study reported multiple adjustment models. Five of the contacted authors have
Fig 1. Flow diagram of study selection. Published studies were retrieved from the MEDLINE-PubMed and
EMBASE databases. TB: tuberculosis; DM: diabetes mellitus.
https://doi.org/10.1371/journal.pone.0187967.g001
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provided us with adjusted estimates [7, 20–23]. Two adjusted estimates [24, 25] were extracted
from a previous review [13].
We evaluated each study’s risk of bias (ROB) using nine domains for cohort and cross-sec-
tional studies, and eleven domains for case-control studies. The ROB domains were adapted
from Cochrane guidelines for systematic reviews [26, 27] and other validated quality assess-
ment tools [28, 29]. The utilized ROB domains are presented in the S2 Box and were related to
different quality criteria such as rigor of sampling strategy, TB and DM case definition and
ascertainment, and DM timing in relation to TB. In case-control studies, convenience sam-
pling of TB cases was considered as a probability-based sampling method as long as all cases in
the sampling frame were selected. Based on the composite scores of the ROB domains, each
cohort or cross-sectional study was classified as “potentially of low ROB” (score7) or “poten-
tially of high ROB” (score<7). Each case-control study was classified as “potentially of low
ROB” (score9) or “potentially of high ROB” (score<9) (S2 Box).
Statistical analysis
For studies reporting stratified crude estimates, we calculated an overall adjusted estimate by
only one stratification if there was an overlap with other strata. In such studies, we prioritized
pooling crude estimates that stratified by co-morbidity, location, age, or sex, consecutively.
When there were two or more levels of stratification without overlap, we pooled estimates for
this sub-levels stratification. If a study stratified estimates according to DM type, we pooled the
overall adjusted estimate regardless of the DM type.
In sensitivity analyses, we pooled estimates of studies of “potentially low ROB”, studies
unlikely to contain duplicate individual–level data, and studies in the general population rather
than specific clinical populations. We further pooled estimates stratified by potential for dupli-
cate data on same patients, country-income level, background TB incidence (50 or >50
cases per 100,000 person-year), region, and TB and DM ascertainment methodology. We
obtained relevant data on TB incidence from the included studies or from the closest matching
year made available by public databases.
We pooled adjusted estimates stratified by study design and regardless of study design
using random-effects model [30]. Cochran’s Q statistic was used to test for evidence of hetero-
geneity [31, 32]. We estimated the I-squared (I2) as a measure of heterogeneity. We computed
Tau-squared (τ2) to estimate the between-study variance of the true association between TB
and DM [31, 32].
We assessed the presence of publication bias by examining the funnel plots using Egger’s t
statistic to examine asymmetry (S2 Fig) [33]. We used the pooled effect estimate in four pro-
spective studies to estimate the attributable risk fraction of DM in developing active TB among
people with DM and to estimate the population attributable risk fraction of DM in developing
active TB among the entire population in six high-TB-burden countries (India, Indonesia,
China, Nigeria, Pakistan, and South Africa), that accounted for 60% of new TB cases in 2015
[1]. Calculations are presented in the S1 Text.
All Statistical analyses were performed using STATA SE 14 (Stata Corporation, College Sta-
tion, TX) [34].
Results
We identified 19,963 publications, 44 of which were found relevant and included in this sys-
tematic review and meta-analysis (Fig 1) [5–12, 20–25, 35–64]. The included studies consisted
of 58,468,404 subjects and 89,592 TB cases and they were set in 16 countries. Most studies
were conducted in Taiwan (11 studies) and USA (11 studies), while only one study was in
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Africa [59]. Two studies of different designs stratified patients according to DM type (1 or 2)
[9, 51], one study was in patients with type 1 DM [48], while the rest of the studies were either
among type 2 DM patients or the type of DM was not specified (presumably, type 2 DM as it is
more prevalent). There were four prospective [8, 23, 35, 36], 19 retrospective [5–7, 20, 22, 24,
37–49], 17 case-control [9–11, 21, 25, 50–61], and three cross-sectional [12, 62, 63] studies.
One study was classified as “other” as the exact study design could not fit into the other catego-
ries [64]. One of the prospective studies was among people aged65 years [35] and one was
among renal allograft recipients [36]. Four of the retrospective studies were among renal
patients [7, 24, 37, 41]. Several studies were national in scope, thereby including the national
population as the study sample size, such as for a study from Australia [47]. Seven retrospective
studies in Taiwan [22, 37, 40–43, 48] and one retrospective and one case-control-study in the
United kingdom, and three cross-sectional [12, 62, 63] studies. One study was classified as
“other” as the exact study design could not fit into the other categories [64]. One of the pro-
spective studies was among people aged65 years [35] and one was among renal allograft
recipients [36]. Four of the retrospective studies were among renal patients [7, 24, 37, 41]. Sev-
eral studies were national in scope, thereby including the national population as the study sam-
ple size, such as for a study from Australia [47]. Seven retrospective studies in Taiwan [22, 37,
40–43, 48] were potentially duplicate studies using the same database with overlapping years.
One cross-sectional study was set in 46 countries and one retrospective and one case-control-
study in the United kingdom [38, 53] were potentially duplicate studies using the same data-
base with overlapping years. One cross-sectional study was set in 46 countries [62].
In prospective studies, estimates were adjusted at least for age except for one study that
reported sex-specific crude estimates [8]. For the latter we pooled these for the present review.
In one prospective study the effect estimate was not adjusted for sex [36]. In retrospective stud-
ies, all estimates were adjusted at least for age or sex. In case-control studies, estimates were
adjusted at least for age and sex except in two studies where the estimate was adjusted for age
but not for sex [54, 55]. All cross-sectional studies were adjusted at least for age and sex. Base-
line characteristics of all included studies are shown in Tables 1 and 2.
The strongest estimate of the TB–DM association was 7.83 (95% CI 2.37–25.09) in a case-
control study from Russia [58] followed by 7.58 (95% CI 2.94–19.49) in a prospective study
from USA [23]. The lowest effect estimate was 1.00 (95% CI 0.69–1.44) in a retrospective study
from Canada [49] followed by 1.16 (95% CI 0.58–2.32) in a case-control study from USA [61].
All four prospective studies demonstrated a positive association (p<0.05). Fourteen of the 19
retrospective [20, 22, 24, 38–48] and 12 of the 17 case-control studies [10, 11, 25, 50, 52–54,
56–60] demonstrated a positive association (p<0.05) between DM and TB (Tables 1 and 2).
In the four prospective studies, DM was associated with 3.59–fold (95% CI 2.25–5.73)
increased risk of TB. The I2 was estimated at 77.9% indicating that most variation across stud-
ies was due to heterogeneity in effect size rather than chance. In 16 retrospective studies, DM
was associated with 1.55–fold (95% CI 1.39–1.72) increased risk of TB (I2 = 77.1%). In the 17
case-control studies, DM was associated with 2.09–fold (95% CI 1.71–2.55) increased risk of
TB (I2 = 79.5%). In the three cross-sectional studies, DM was associated with 1.70–fold (95%
CI 1.28–2.24) increased risk of TB (I2 = 28.9%) (Table 3). In all studies regardless of study
design, DM was associated with 2.00-fold (95% CI 1.78–2.24) increased risk of TB (I2 =
90.5%). Forest plots of meta-analysis according to study design are shown in Fig 2 with sum-
mary findings presented in Table 3.
All of the four prospective studies were judged of “potentially low ROB”. Except one study
[6], the 16 retrospective studies reporting relative risk (RRs), hazard ratio (HR), or rate ratio
(RR), were judged of “potentially low ROB”. Of the 17 case-control studies, 13 were judged of
“potentially low ROB” [9–11, 25, 50–54, 56, 57, 59, 61] (S1 Table).
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In the sensitivity analyses presented in S1 Table, restricting the meta-analyses to studies
judged of “potentially low ROB”, among only the general population, and with no potential for
duplicate data on the same patients, DM patients were overall, that is by including all studies
regardless of study design, at 2.00–fold (95% CI 1.77–2.27), 2.12–fold (95% CI 1.82–2.48),
1.63–fold (95% CI 1.45–1.82), respectively, increased risk of TB compared to the original over-
all estimate including all studies of 2.00–fold (95% CI 1.78–2.24) increased risk of TB
(Table 3).
Moreover, overall, DM patients in low- or middle-income countries (3.16, 95% CI 2.20–
4.53), in settings with TB incidence >50 cases per 100,000 person-year (2.05, 95% CI 1.80–
2.33), or in Asian continent (2.46, 95% CI, 2.04–3.02) were at higher risk of TB than DM
patients in high-income countries, in settings with TB incidence50, or in Europe or USA
and Canada, respectively (S1 Table).
In two prospective studies [8, 35], with microbiologically defined TB, and with blood test-
ing for DM, patients were at 3.67–fold (95% CI 2.01–6.70) increased risk of TB. Overall, DM
patients with microbiologically defined TB were at 3.03-fold (95% CI 2.31–3.98) increased risk
of TB compared to 1.58–fold (95% CI 1.46–1.71) and 1.73–fold (95% CI 1.36–2.20) based on
medical records or self-reported TB, respectively. Overall, blood tested DM patients were at
3.10–fold (95% CI 2.02–4.74) increased risk of TB compared to 1.60-fold (95% CI 1.18–2.17)
and 1.95-fold (95% CI 0.90–4.25) based on medical records or self-reported DM, respectively
(S1 Table).
Table 3. Summary findings of the meta-analyses for the association between DM and active TB, according to study design.
Studies Study
population
Effect estimate Pooled estimate Heterogeneity measures




95% CI Q (p-value)1 τ2 2 I2 3
Study design
Prospective 4 872,269 RRs/HR 2.24–7.58 3.59 2.25–5.73 13.55 (p = 0.004) 0.1619 77.9%
Retrospective 16 56,990,255 RRs/RR/HR 1.00–4.23 1.55 1.39–1.72 65.45
(p < 0.0001)
0.0220 77.1%
Retrospective 3 9,949 OR 1.42–3.59 1.69 1.35–2.12 1.87 (p = 0.392) 0.0000 0.0%
Case-control 17 250,720 OR 1.16–7.83 2.09 1.71–2.55 77.88
(p < 0.0001)
0.1010 79.5%
Cross-sectional 3 327,952 OR 1.40–3.17 1.70 1.28–2.24 2.81 (p = 0.245) 0.0184 28.9%
Other4 1 21,230 RR 6.00 6.00 5.00–7.20 –5 –5 –5
Overall6 44 58,472,375 OR/RRs/RR/HR 1.00–7.83 2.00 1.78–2.24 451.95
(p < 0.0001)
0.0945 90.5%
1 Q: Cochran Q statistic is a measure assessing the existence of heterogeneity in estimates of association between TB and DM.
2 τ2: the estimated between–study variance in the true association between TB and DM estimates. The τ2 is for the variance of beta not for the back-
transformed estimate.
3 I2: a measure assessing the magnitude of between-study variation that is due to differences in the association between TB and DM estimates across
studies rather than chance.
4 Study by Ponce-de-Leon A., et al.,[64] neither categorized as prospective, retrospective, cross–sectional, or case–control study. Effect estimate is the
individual study effect estimate.
5 Meta-analysis was not conducted due to limited number of studies (one study).
6 Overall estimate including risk ratios, rate ratios, hazard ratios, and odds ratios, that is regardless of the measure of association and study design.
Background incidence rate of TB did not exceed 2 per 100 person-year in studies estimating an OR, therefore it is reasonable to assume that TB is
sufficiently rare so that the ORs would estimate the risk ratios. Pooled estimate was implemented using a random-effects model.
RRs: relative risk; OR: odds ratio; HR: hazard ratio; RR: rate ratio; CI: confidence interval.
https://doi.org/10.1371/journal.pone.0187967.t003
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Overall, DM patients with HbA1c 6.5%, FBG 120 mg/dl, or on insulin treatment, were
at 1.87–fold (95% CI 1.19–2.93), 3.30-fold (95% CI 2.12–5.14), or 2.51–fold (95% CI 1.62–
3.87) increased risk of TB, respectively (S2 Table).
In the four prospective (p = 0.495), 16 retrospective that reported RR, RRs, or HR
(p = 0.439), three retrospective that reported an OR (p = 0.864), and three cross-sectional
(p = 0.696) studies, reporting on the association between DM and TB, the Egger’s t statistic for
asymmetry in the funnel plot indicated no evidence for the presence of a small-study effect
(S2a, S2b, S2c and S2d Fig, respectively). However, in the 17 case-control studies, the Egger’s
Fig 2. Forest plot of the meta-analyses. Pooled findings of 44 studies reporting adjusted estimates of the
association between TB and DM, stratified according to study design. Size of the square is proportional to the
precision (weight) of the study-specific effect estimates. Circle is the study–specific effect point estimate.
Arrows indicate that the bars are truncated to fit the plot. The diamond is centered on the summary effect
estimate, and the width indicates the corresponding 95% CI. RRs: relative risk; RR: rate ratio; OR: odds ratio;
HR: hazard ratio.
https://doi.org/10.1371/journal.pone.0187967.g002
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t statistic for asymmetry in the funnel plot indicated evidence for the presence of a small-study
effect (p = 0.005) (S2e Fig).
With a summary RRs of 3.59 among DM patients in the four prospective studies, DM
accounts for 72% of active TB cases among strictly DM patients (attributable risk fraction). In
the six high-TB-burden countries (India, Indonesia, China, Nigeria, Pakistan, and South
Africa), that accounted for 60% of new TB cases in 2015, 18%, 14%, 22%, 11%, 15%, and 15%
of active TB cases in the entire population in these countries is attributed to DM, respectively.
For the population attributable risk fraction, calculations are presented in S1 Text.
Discussion
In this systematic review and meta-analysis of studies on the TB–DM association, we identified
a strong positive association, but with substantial heterogeneity in effect size between studies.
Stronger associations were noted among DM patients where TB was confirmed microbiologi-
cally, where DM ascertainment was based on blood testing (rather than self-report or medical
records only), and among DM patients with uncontrolled blood glucose. This most compre-
hensive review and meta-analysis included 44 observational studies, compared to nine and 13
[13] studies in the previously published two reviews, one of which included a meta-analysis of
prospective studies [13]. With this increase in published evidence, our meta-analysis con-
firmed the result of the earlier meta-analysis [13] and strengthened the evidence base for a
strong association between DM and active TB. Our results demonstrated consistent evidence
of a two- to four-fold increased risk of developing TB disease for DM patients compared to
non-DM patients.
As a result of aging and increasing prevalence of major DM risk factors; particularly obesity
and tobacco use [1, 67–69], it is projected that the number of individuals with DM will rise
from 415 million in 2015 to 642 million by 2040 [3]. With the observed TB relative risk of 3.59
among DM patients in prospective studies, DM will therefore account for an increasing frac-
tion of active TB cases in the entire population in the future. A frequent misperception is that
chronic diseases such as DM are diseases of affluence [20, 70], in fact they are also common
amongst poorer populations, where infectious diseases such as TB remain prevalent. Estimates
suggest that the DM burden is increasing fastest in those regions where TB remains endemic
[46]. From a public health perspective, it is of note that there are now more TB patients with
concomitant DM than with HIV [71]. Given these findings, it may be challenging to control
TB, particularly in settings that experience the double burden of the twin–epidemic of TB and
DM. Robust public health intervention programs should consider tackling the underlying fac-
tors of DM such as lack of physical activity and obesity. As well as, programs to screen DM
patients for TB alongside controlling blood glucose in TB patients to improve TB/DM treat-
ment outcomes and to control this “twin epidemic”. Our findings strengthen the evidence
base for how DM can impact upon the achievements of the WHO “End TB Strategy” [1].
The observed slight discrepancy in the summary estimate in the present and the previous
meta-analysis [13] is partially due to the fact that one of the prospective studies [24] included
in the previous meta-analysis was classified as retrospective in our review. Also, we used esti-
mates from more confirmatory TB (bacterial culture confirmed rather than X-ray ascertained
TB) and DM (HbA1c rather than FBG ascertained DM) ascertainment criteria that adjusted
for the largest number of variables to pool strata-specific estimates, which in turn would pro-
duce more reliable association between TB and DM. In the previous meta-analysis [13], the
estimate obtained from Kim et al., 1995 [8] was age-adjusted for all types of TB using a fixed-
effect model, whereas we adjusted for sex for bacteriologically proven TB only, using a ran-
dom-effects model. Moreover, we identified two more prospective studies [23, 35] that
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contributed 44% of the weight in our summary estimate. However, excluding one of these two
studies, as DM and one-third of TB cases were ascertained by “self-report”, the summary esti-
mate was 3.18 (95% CI 1.95–5.18), which is more comparable to that reported in the previous
meta-analysis [13]. In the prospective studies, DM was mostly ascertained prior to the develop-
ment of TB, suggesting that DM increases the risk of developing active TB, though some stud-
ies screened for DM at the time of TB diagnosis, and thus infection-related hyperglycemia
could also explain some of the association.
We conducted sub-group sensitivity analyses to assess the heterogeneity in effect size. Sev-
eral factors appeared to have contributed to this heterogeneity, including sampling methodol-
ogy, study subjects, year of study, geographical location, exposure and outcome ascertainment
methodology, variability within the specific subpopulation studied, sex and age-group repre-
sentation in the sample, and publication bias. However, with the relatively small number of
outcome measures according to study design, it was not possible to quantify the contribution
of these sources of variation to the heterogeneity in the association through a meta-regression
analysis.
All included studies were adjusted for at least age or sex, and estimates from majority of
studies were also adjusted for different demographic and other potential confounders. This
ensured that overall summary estimates were adjusted for at least the major confounding
effects of age or sex. The strongest TB–DM association was observed from the four prospective
studies [8, 23, 35, 36]. Data from almost three-quarters of included studies were representative
of the general population. In studies reporting more than one adjusted estimate or strata-spe-
cific estimates, we included the estimates with more confirmatory ascertainment criteria for
TB and/or DM, and that adjusted for the largest number of variables. This in turn produced
summary estimates with lower potential of including false positive or false negative DM or TB
cases. Overall, limiting the meta-analysis to studies judged as “potentially of low ROB” and
excluding potentially duplicate studies did not change the direction nor magnitude of the
association.
In the present review, the overall summary estimate in settings with TB incidence >50
cases per 100,000 person-year showed stronger association compared to that in settings with
TB incidence50 (S1 Table). This is in line with the findings of the previous meta-analysis
[13]. Dobler et al., 2012 [47], hypothesized that the reason for the stronger association in set-
tings with higher TB incidence could relate to the quality of diabetes management, assuming
healthcare services may be poorer or harder to access in higher TB incidence settings.
We noticed a stronger association in blood-tested DM patients. DM patients with well-con-
trolled glucose levels are less likely to be included when the definition of DM is based on blood
glucose levels, which implies that hyperglycaemia rather than a DM diagnosis per se, increases
the risk of TB [47]. DM patients suffer from immune system impairments, resulting in a lack
of energy supply to immune cells, that subsequently increases virulence of infectious microor-
ganisms [72–75]. These impairments weaken the immune system response to Mycobacterium
tuberculosis [76–78]. This is supported by the observed stronger association in patients with
uncontrolled blood glucose level (FBG120 mg/dl or HbA1c6.5%) (S2 Table).
There are several biological mechanisms that appear to alter the immune system and by
which DM patients may develop TB [72–84]. High levels of insulin were associated with a
decrease in T helper 1 (Th1) immunity through a reduction in the Th1 cell to T helper 2 (Th2)
cell ratio and interferon-c (IFN-c) to interleukin-4 (IL-4) ratio [80]. Other studies showed that
nonspecific IFN-c levels were significantly reduced in people with diabetes compared to people
with no diabetes [81], and that levels of IFN-c were negatively correlated with levels of HbA1c
[82]. Neutrophils in people with diabetes were found with a lack in chemotaxis and oxidative
killing potential compared to non-diabetic controls [83]. Leukocyte bactericidal activity was
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found to be reduced in people with diabetes, especially those with poor glucose control [84].
These observed immunologic alterations seen in people with diabetes have also been supported
in experimental animal studies. Diabetic mice experimentally infected with Mycobacterium
tuberculosis have higher bacterial loads compared to euglycemic mice [85, 86] with signifi-
cantly lower production of IFN-c and interleukin-12 and fewer T cells [86].
Several of the included studies had methodological weaknesses. Eight studies [5, 12, 23, 52,
54, 55, 61, 62] relied on “self-reported” DM and four studies [12, 23, 54, 62] relied on “self-
reported” TB. Studies that utilized blood tests to define DM may also have reported stronger
associations between DM and TB, since they can identify undiagnosed DM [13], which is com-
mon in many low–and middle–income countries. In studies that relied on “self-reported”
DM, subjects with controlled blood glucose (euglycemic) would be “misclassified” as DM
patients. This assumption is supported in our sensitivity analyses (S1 Table). There is an addi-
tional potential misclassification of TB and DM cases as studies often used routinely collected
data without validation using laboratory tests [38]. For instance, a single HbA1c measurement
might misclassify individuals as either DM or non-DM patients. It is recommended that DM
diagnosis should be confirmed with a repeat HbA1c test, unless clinical symptoms and plasma
glucose levels >11.1mmol/l (200 mg/dl) are present [87]. Missing adjustment for potential
confounders is also a noteworthy limitation. In six studies [16, 45–48, 76], estimates were
adjusted only for age and/or sex. Individual studies that controlled for the influence of age, sex,
and smoking [35, 53, 58] produced stronger estimates than those controlled for age and sex
[20, 43, 47]. Biased estimates on the TB–DM association may have occurred in studies among
patients receiving dialysis [24, 41] or among subjects from specialty clinics or hospitals rather
than the general population [88]. In almost all case-control studies, sampling of cases and/or
controls was based on non-probability sampling. Studies using hospital-based controls
reported weaker estimates for the association [13].
DM can affect different aspects of TB natural history and treatment outcomes, and there-
fore can impact TB transmission dynamics. An ongoing study has identified seven epidemio-
logically-relevant plausible effects for DM on TB natural history, and three for DM on TB
treatment outcomes [89]. Our study, however, was focused on one major aspect of the TB–
DM synergy, that of the association between DM status and active TB disease diagnosis—we
did not assess other aspects of this synergy such as effects of DM on TB infection acquisition,
TB reactivation among those latently infected, TB infectiousness, or TB treatment outcomes.
A recent review, for example, reported that DM increases risk of latent TB by 1.18–fold [14],
though with substantial heterogeneity across studies, and other studies have demonstrated
major effects for DM on TB treatment outcomes [15–17]. Comprehensive and granular char-
acterization and quantification of the diverse effects of DM on TB is essential for a proper
understanding and estimation of the impact of DM on TB epidemiology.
In most of included studies, type of DM was unclear, thereby limiting our ability to assess
the association by DM type (1, 2, or both). Having said so, in the three studies that assessed the
association of TB with type 1 DM [9, 48, 51], the effect size was comparable to that seen for
type 2 DM studies. HIV/AIDS is a strong risk factor for TB [90], but only a fraction of included
studies controlled for its effect in their assessment of the association. This may not affect
appreciably our results, as HIV prevalence is very low in nearly all countries where the associa-
tion was assessed. Age is another confounding factor for the TB–DM association, and nearly
all studies controlled for this factor. Our study was focused on the overall effect of DM on TB
disease, and we did not provide a pooled effect size stratified by age. Despite these limitations,
our review and meta-analyses compiled and summarized important data and critically pro-
vided narrative information from a large number of studies that reported on the TB–DM
association.
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Conclusions
Our systematic review and meta-analysis demonstrated consistent evidence of a substantially
increased risk of TB disease among people with DM. This evidence was based on data from
studies using different designs and reported from six continents. DM patients with uncon-
trolled blood glucose (measured by higher FBG or HbA1c) appeared to be at higher risk of
active TB than patients with controlled DM. Efforts to halt the burgeoning DM epidemic
would have an accompanied benefit of alleviating the global burdens of DM and TB. The bur-
geoning epidemic of DM is likely to impact upon the achievements of the WHO “End TB
Strategy”. Our findings inform strategy planning of health service provision and implementa-
tion of effective prevention programs to control the “twin epidemic” of DM and TB.
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